Top

AEterna Zentaris Inc.

TSX Exchange | Jul 5, 2020, 12:22 PM EDT | Real-time price

AEZS $ 0.52 RT
CHANGE
0.02 (4.00%)
VOLUME
451,165
Day Low: 0.51
Day High: 0.58
Detailed Quote
Open: 0.54
High: 0.58
Beta: 2.6767
Listed Shares Out.1: 20,031,610
Total Shares (All Classes)2: 23,584,071
Prev. Close: 0.50
Low: 0.51
VWAP: 0.5517
Market Cap1: 10,416,437
Market Cap (All Classes)2*: 12,263,717
Dividend: N/A
Div. Frequency: N/A
P/E Ratio: N/A
EPS: -0.81
Yield: N/A
Ex-Div Date: N/A
P/B Ratio: -4.00
Exchange: TSX

(1) Number based only on listed classes of shares.

(2) Number sourced from third party data provider. For the most up to date information, please refer to the company's financial documents.

*Market Capitalization is based on Total Shares Outstanding for all share classes for the company. Convertible bonds and employee stock options that would otherwise be included in the Diluted Shares amount included in a company's filings/financials are not included.

Description

AEterna Zentaris Inc is a biopharmaceutical company commercializing & developing therapeutics & diagnostic tests. The company's product, Macrilen (macimorelin), is the oral test indicated for the diagnosis of adult growth hormone deficiency (GHD). Macrilen is marketed in the U.S. through a license agreement with Novo Nordisk & the company receives royalties on sales. Aeterna owns all rights to macimorelin outside of the U.S. & Canada. It is leveraging the clinical success & safety profile of mac... More

News Headlines for AEterna Zentaris Inc.
Research
News Headlines for AEterna Zentaris Inc.
Last 25 Trades
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. View delay times for all exchanges. Market Data powered by QuoteMedia, Fundamentals by Morningstar. See the QuoteMedia Terms of Use.